focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,150.00
Bid: 12,148.00
Ask: 12,152.00
Change: -22.00 (-0.18%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

Mon, 03rd Jul 2023 09:07

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

The FTSE 100 index opened up 18.52 points, 0.3%, at 7,550.05. The FTSE 250 was up 72.89 points, 0.4%, at 18,489.65, and the AIM All-Share was up 0.65 point, 0.1%, at 754.16.

The Cboe UK 100 was up 0.2% at 753.09, the Cboe UK 250 was up 0.3% at 16,141.46, and the Cboe Small Companies was up 0.1% at 13,727.97.

"The FTSE 100 opened marginally higher, helped by the tailwinds of a strong session in Asia and on Wall Street on Friday. But it's still struggling to find significant momentum, dragged down by concerns about growth in China and the wider global economy," commented Hargreaves Lansdown's Susannah Streeter.

In European equities, the CAC 40 in Paris was up 0.2%, while the DAX 40 in Frankfurt was up 0.3%.

Shares in Tesla were up 5.2% in Frankfurt after the US automaker said deliveries in the second quarter beat market estimates.

The electric car maker delivered 466,140 vehicles, an 83% increase year-on-year and above estimates of 450,000.

"The electric vehicle giant has benefitted from US federal credits which are designed to encourage consumers to shift away from diesel and petrol cars," interactive investor's Victoria Scholar said. "Its strategy to cut prices this year has also paid off amid the macroeconomic headwinds but could weigh on profit margins ahead."

Tesla's production is still a long way below that of major car makers such as Toyota, which produced nearly 950,000 vehicles in May alone this year.

In Asia on Monday, markets took their cue from the strong performance on Wall Street, despite some mixed economic data for the region.

The Nikkei 225 index in Tokyo closed up 1.7%, with Toyota up 0.7%.

In China, the Shanghai Composite closed up 1.3%, while the Hang Seng index in Hong Kong was up 2.3%. The S&P/ASX 200 in Sydney closed up 0.6%.

Early economic data pointed towards a slowdown in Asian manufacturing.

The Caixin purchasing managers' index for China's manufacturing indicated marginal growth in June, albeit at a slower pace than in May. Meanwhile, the au Jibun Bank PMI for Japan showed its manufacturing sector slipped back into a slight contraction. Respondents in Japan noted especially weak demand from mainland China, with exports orders continuing to fall.

In the US on Friday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.8%, the S&P 500 up 1.2% and the Nasdaq Composite up 1.5%. Sentiment was lifted by a cooler-than-expected US inflation print, which boosted hopes that the Federal Reserve's rate-rising spree might be close to an end.

Still, the dollar was firm against other major currencies in early exchanges in Europe on Monday.

Sterling was quoted at USD1.2670, lower than USD1.2706 at the London equities close on Friday. The euro traded at USD1.0880, lower from USD1.0916. Against the yen, the dollar was quoted at JPY144.75, up versus JPY144.58.

In London, supermarket chain Tesco rose 0.9% as it named Gerry Murphy as its new chair from September 1.

Murphy is currently chair of luxury fashion firm Burberry and food supplier Tate & Lyle, and will step down from his role at the latter to "ensure he has sufficient capacity" for his new role at Tesco.

Murphy was also previously CEO at Kingfisher, and has held non-executive directorships at companies including British American Tobacco and Reckitt Benckiser.

Shares in Tate & Lyle fell 0.5%, while Buberry was trading flat.

Anglo American rose 2.3%, as it announced late on Friday that its diamond business, de Beers, reached an eleventh-hour deal with the Botswanan government. This followed months of tense negotiations that saw the continent's top producer threatening to cut ties with the storied diamond company.

The Botswana government and Anglo-American, have reached an "agreement in principle", the two sides said in a statement issued late Friday. The agreement provides for a new 10-year agreement to sell the rough diamonds produced by Debswana – a joint venture equally owned by the government and De Beers – and a 25-year extension of its mining licenses.

AstraZeneca fell 5.9% in early trade - the worst large-cap performer - as it announced high-level results from the Tropian-Lung01 phase III trial.

The trial looked at datopotamab deruxtecan, or Dato-DXd, in advanced non-small cell lung cancer. In patients will locally advanced or metastatic NSCLC treated with at last one prior therapy, the treatment showed a "statistically significant" improvement for the dual primary endpoint of progression-free survival compared to docetaxel, the current standard of care chemotherapy.

However, for the dual primary endpoint of overalll survival, the data "were not mature".

"An early trend was observed in favour of datopotamab deruxtecan versus docetaxel that did not meet the prespecified threshold for statistical significance at this interim analysis," AstraZeneca said.

The trial will continue as planned in order to assess OS with greater security.

On AIM, Yourgene Health more than doubled in value, with its shares reaching 0.47 pence from 0.20p on Friday.

The molecular diagnostic group has agreed a cash takeover offer with Novacyt UK, a wholly-owned subsidiary of fellow AIM listing Novacyt. The offer of 0.522p a share values the company at GBP16.7 million.

Novacyt is a biotechnology group focused on clinical diagnostics. Its shares were up 16%.

"The acquisition combines highly complementary technologies and services, with the enlarged group able to leverage mutual research and development capabilities for ongoing product development and portfolio enhancement to improve the customer offering," the companies said.

Gold was quoted at USD1,916.08 an ounce early Monday, higher than USD1,915.48 on Friday. Brent oil was trading at USD75.28 a barrel, little changed from USD75.58

There are more manufacturing PMI readings to come, including the UK at 0930 BST and the US at 1445 BST.

Financial markets in New York close at 1300 local time on Monday for Independence Day. They stay closed on Tuesday for the US public holiday.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
Today 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.